Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Analysis: BTC market share is about to break through multi-year support levels, which may indicate the arrival of altcoin season

Analysis: BTC market share is about to break through multi-year support levels, which may indicate the arrival of altcoin season

Bitget2024/12/02 01:17

Data shows that BTC's market share has dropped from 60% over the past month to below 57% (currently at 56.7%). Analysts predict that BTC's market share seems about to break through its multi-year support trend line. In addition, ETH's market share also fell to 12.9%, while other cryptocurrencies' market shares rose to 31.5%, higher than last month's 28.1%. Analysis points out that the significant drop in BTC's market share has significantly affected the market sentiment, indicating that the altcoin season has arrived.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

According to a report by Mizuho Securities analysts, following a series of recent system failures in the United States, consumers have started stockpiling essential goods, leading to a short-term surge in demand for Costco, a members-only retailer.

智通财经•2026/11/18 03:07
Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years

Biogen has released the latest interim clinical trial data for its early-stage Alzheimer's disease candidate drug, diranersen.

智通财经•2026/11/18 03:02
Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years

Nvidia Acting CEO Kress Reassures the Market: No Customer Loss and No Employee Exodus

Nvidia released its first quarterly financial report since Jensen Huang's resignation, after which Colette Kress told the media that major client demand has not been affected and the workforce remains stable, emphasizing that "everything is business as usual." The company's share price rose over 3% after hours, though the stock is still down 24% for the month.

华尔街见闻•2026/11/18 02:41